Abstract
Initially recognised as an important factor for bone health, vitamin D is now known to have a range of effects on the immune system. Vitamin D deficiency is associated with an increased risk of multiple sclerosis (MS), a chronic immune-mediated demyelinating disease of the CNS. In this review, we explore the links between vitamin D deficiency, MS risk, and disease activity. We also discuss the known immune effects of vitamin D supplementation and the relevance of these observations to the immunopathology of MS. Finally, we review the existing evidence for vitamin D supplementation as an MS therapy, highlighting several recent clinical studies and trials.
Original language | English |
---|---|
Pages (from-to) | 4113-4133 |
Number of pages | 21 |
Journal | British Journal of Pharmacology |
Volume | 177 |
Issue number | 18 |
DOIs | |
Publication status | Published - Sept 2020 |
Keywords
- cholecalciferol
- genetic
- immune
- multiple sclerosis
- supplementation
- therapeutic
- transcriptome
- treatment
- vitamin D